Publications by authors named "Martina Pavletic-Persic"
Scope: Oleuropein possesses numerous health beneficial effects. We investigated the renoprotective effects of oleuropein against cisplatin (CP) induced kidney injury.
Methods And Results: Male BALB/cN mice were orally gavaged with 5, 10 and 20 mg oleuropein/kg body weight for 2 days, 48 h after intraperitoneal injection of CP (13 mg/kg).
Article Synopsis
- The study investigates the use of high-dose intravenous immunoglobulin (IVIG) as the first-line treatment for patients experiencing acute humoral rejection (AHR) after kidney transplant at the University Hospital Rijeka, Croatia.
- Eight kidney transplant recipients were evaluated, with signs of renal dysfunction and confirmed AHR through biopsies showing positive C4d-staining.
- Results showed that high-dose IVIG is effective, safe, and well tolerated in treating AHR, with varying responses observed depending on whether it was used alone or following plasmapheresis.
Accumulating data from observational studies showed that online hemodiafiltration (OLHDF) might improve survival in chronic hemodialysis (HD) patients. According to this data, the aim of our study was to investigate whether there was a difference in survival of patients treated with OLHDF compared to standard, conventional HD. We included 85 prevalent patients with end-stage renal disease (ESRD) treated with HD as a method of renal replacement therapy (RRT) for more than three months.
View Article and Find Full Text PDFThe role of renin-angiotensin system inhibitors (ACE-inhibitors) or angiotensin receptor blockers (ARB) in the renal transplant recipients (RTRs) is incompletely defined and according to the current guidelines they should be initiated after six months post-transplantation. The aim of the present paper is to evaluate the efficiency and safety of early (within six months post-transplantation) versus late (after six months post-transplantation) initiation of ACE-inhibitors or ARB in RTRs. The study group compromised of 108 RTRs (50 male and 58 female) who received a kidney transplant.
View Article and Find Full Text PDFBackground And Aim: The mortality of chronic kidney disease patients is very high. Patients on chronic renal replacement therapy are also et very high mortality risk. Nevertheless, by the advance in renal replacement therapy the surveillance of these patients could be long with reasonable quality of life.
View Article and Find Full Text PDF